The quality of articles published in the journal is also reflected in its most recent impact factor (3.435). The journal is in Quartile 1 of the all three JCR categories it is ranked in, namely Public Environmental & Occupational Health, Pharmacology & Pharmacy, and Toxicology.
Other journals in the Adis Premier Journals Portfolio (http://www.springer.com/gp/adis) continue to prosper, and this year has seen the successful launch of PharmacoEconomics -Open, the newest journal in the portfolio. The journal has published a full volume of 30 articles in its first year, plus many more online first. Following in the steps of Adis' flagship subscription journal in the field, PharmacoEconomics, the new open-access journal focuses on cost and health outcomes associated with drugs, devices and other healthcare interventions.
We thank the authors who have contributed articles to Drug Safety over the course of 2017. The skill and dedication of all authors are critical to the continued publication of the journal. The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal's content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for Drug Safety in the last 12 months:
Todd Lee, Canada
